Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,630.55", "chg": 22.1, "chgp": "0.39%", "dir": 1, "prev_price": "5,608.45", "mcapval": "66,747.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "Aug 07, 03:30 PM", "curr_time": "17:56 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "79.02 k", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alkem Laboratories Declines 2.13% Amid Downgrade and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-213-amid-downgrade-and-valuation-concerns-4143214", "imagepath": "", "date": "2026-08-08 13:10:37", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Mojo Grade downgraded to Sell amid mixed financial and technical signals</p>\n <p><strong>4 Aug:</strong> Technical momentum shifts to sideways with mixed indicator readings</p>\n <p><strong>5 Aug:</strong> Valuation metrics move to expensive territory, signalling reduced price attractiveness</p>\n <p><strong>7 Aug:</strong> Week closes at ₹5,630.55, down 2.13% for the week versus Sensex +1.13%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\">\n <div class=\"stat-label\">Week Open</div>\n <div class=\"stat-valu..." }, { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Price Attractiveness Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-price-attractiveness-decline-4136902", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_valuationdot_4136902.png", "date": "2026-08-05 08:03:03", "description": "Alkem Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating as of early August 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a reappraisal of the stock’s price attractiveness relative to its historical averages and peer group." }, { "title": "Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4135854", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_mojoScore_4135854.png", "date": "2026-08-04 08:56:14", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 3 August 2026. This shift reflects a complex interplay of deteriorating technical indicators, subdued financial trends, and cautious valuation metrics, despite the company’s strong operational efficiency and long-term market outperformance." }, { "title": "Alkem Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-signals-4135162", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_technicaldot_4135162.png", "date": "2026-08-04 08:08:57", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators present a nuanced picture for investors navigating the current market environment." }, { "title": "Alkem Laboratories Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-hold-by-marketsmojo-4131156", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_mojoScore_4131156.png", "date": "2026-08-01 10:10:36", "description": "Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 01 August 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and market performance." }, { "title": "Alkem Laboratories Sees Sharp Open Interest Surge Signalling Potential Market Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-signalling-potential-market-shift-4128906", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128906.png", "date": "2026-07-30 15:00:18", "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, supported by robust volume and price action, prompting a reassessment of its market positioning and investor sentiment." }, { "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4128856", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128856.png", "date": "2026-07-30 14:00:15", "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price performance, combined with increased volumes and a notable rise in futures and options participation, suggests evolving investor sentiment in the pharmaceuticals and biotechnology sector." }, { "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4128809", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128809.png", "date": "2026-07-30 13:00:14", "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock, currently trading close to its 52-week high, has outperformed its sector peers amid rising volumes and shifting investor positioning." }, { "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4128740", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128740.png", "date": "2026-07-30 12:00:14", "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume patterns and improving technical indicators, suggesting renewed investor confidence." } ], "total": 636, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "Update On US FDA Inspection At CompanyS Manufacturing Facility Located At Amaliya Daman", "datetime": "06-Aug-2026", "details": "Please find attached herewith intimation about update on US FDA inspection at Companys Manufacturing Facility Located at Amaliya Daman.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "03-Aug-2026", "details": "Please find attached herewith regarding Appointment of Senior Management Personnel.", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "30-Jul-2026", "details": "Please find attached herewith Disclosure under Regulation 30 of the SEBI (LODR) Regulation 2015.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "14 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Aug 26", "dt": "2026-08-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Mojo Grade downgraded to Sell amid mixed financial and technical signals

4 Aug: Technical momentum shifts to sideways with mixed indicator readings

5 Aug: Valuation metrics move to expensive territory, signalling reduced price attractiveness

7 Aug: Week closes at ₹5,630.55, down 2.13% for the week versus Sensex +1.13%

Week Open

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Price Attractiveness Decline

2026-08-05 08:03:03

Alkem Laboratories Ltd has experienced a notable shift in its valuation parameters, moving from a fair to an expensive rating as of early August 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a reappraisal of the stock’s price attractiveness relative to its historical averages and peer group.

Read full news article

Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-08-04 08:56:14

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 3 August 2026. This shift reflects a complex interplay of deteriorating technical indicators, subdued financial trends, and cautious valuation metrics, despite the company’s strong operational efficiency and long-term market outperformance.

Read full news article

Alkem Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals

2026-08-04 08:08:57

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators present a nuanced picture for investors navigating the current market environment.

Read full news article

Alkem Laboratories Ltd is Rated Hold by MarketsMOJO

2026-08-01 10:10:36

Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 01 August 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and market performance.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Signalling Potential Market Shift

2026-07-30 15:00:18

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, supported by robust volume and price action, prompting a reassessment of its market positioning and investor sentiment.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-07-30 14:00:15

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price performance, combined with increased volumes and a notable rise in futures and options participation, suggests evolving investor sentiment in the pharmaceuticals and biotechnology sector.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-07-30 13:00:14

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock, currently trading close to its 52-week high, has outperformed its sector peers amid rising volumes and shifting investor positioning.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-07-30 12:00:14

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume patterns and improving technical indicators, suggesting renewed investor confidence.

Read full news article